Marker Therapeutics Inc (MRKR)

[Rkmatters]

They had no money in those years. Literally operating on a shoe string. The best intentions mean nothing with no money. And so, they pushed through and needed to have strong due diligence to get institutional investors money. That occurred in Dec 2014. By February 2015 they started lining up financing. By May, at ASCO timing, they reported in a big way. And finally by last September with the exercise of warrants they had millions of dollars and the money to finally pay Mayo for the licensing rights on FRa. There was much risk they were going to lose that. That risk went away when Dart stepped in and came on board to buy up 49.9% shares (upon warrant exercise). The reality is that this is biotech and to be in for the true gains you have to get in early and you have to do your due diligence. A company is worthless without strong science. If TPIV wouldn't have been able to secure the licensing it would have been sold to someone else to take to Phase II stage. So for all this talk about how Glynn has failed to keep his promise to us, at an early stage, I suggest folks consider that it is a mighty big accomplishment for a small man team to be able to do what they have done. And now, it's simply a matter of time to just allow them to do their thing. And so this will be my last post on the subject as frankly I'm impressed they brought this biotech stock back from the ashes and at a point to partner with a CI and the likes of Dart. Eom.